InvestorsHub Logo
Followers 69
Posts 7614
Boards Moderated 0
Alias Born 01/10/2014

Re: Investor2014 post# 408740

Tuesday, 03/28/2023 2:12:28 PM

Tuesday, March 28, 2023 2:12:28 PM

Post# of 463454
I think my question is more along the lines of learning about off-label prescribing for ultra rare and rare diseases after any type of approval.

The system and process just seems to take too long and too expensive for those conditions.

I assume for a chance at insurance coverage more P 2/3 trials are needed, right?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News